Showing results (151-160 of 198) with videos related to
Sort By:
Pageof 20
Genes, Chromosomes & Cancer|July 20, 2024
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere MaintenanceAnna Djos, Johanna Svensson, Jennie Gaarder, et al.Plos One|December 17, 2009
DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomasGéraldine Giraud, Torbjörn Ramqvist, Diana V Pastrana, et al.Molecular Oncology|July 31, 2023
High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistanceAhlem Zaghmi, Erdem Aybay, Long Jiang, et al.Cancer Discovery|July 7, 2021
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor ImmunityXiaolei Zhou, Madhurendra Singh, Gema Sanz Santos, et al.Endocrine-Related Cancer|March 31, 2007
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paragangliomaJanos Geli, Nimrod Kiss, Fredrik Lanner, et al.Molecular Cancer|July 10, 2013
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumoursAnnica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, et al.Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.Cell Death & Disease|October 7, 2021
Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compoundTatiana A Giovannucci, Florian A Salomons, Martin Haraldsson, et al.Cancers|December 23, 2023
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX GenesAnna Djos, Ketan Thombare, Roshan Vaid, et al.Frontiers in Pharmacology|September 21, 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironmentEva Proestler, Julia Donzelli, Sheila Nevermann, et al.Pageof 20